Martineau R J, St-Jean B, Kitts J B, Curran M C, Lindsay P, Hull K A, Miller D R
Department of Anaesthesia, Ottawa General Hospital, Ontario.
Can J Anaesth. 1992 Sep;39(7):670-6. doi: 10.1007/BF03008228.
A randomized, double-blind study was undertaken to compare the tendencies for cumulation, and reversal characteristics of atracurium (ATR) and vecuronium (VEC) when administered by continuous infusion for long surgical procedures under balanced anaesthesia. Eligible subjects were between 50 and 75 yr of age and were free of neuromuscular disease. Patients in the ATR group (n = 25) received a loading dose of atracurium 0.25 mg.kg-1, followed by an infusion initially set at 5.0 micrograms.kg-1.min-1. In the VEC group (n = 25) patients received a loading dose of vecuronium 0.05 mg.kg-1, followed by an infusion at 1.0 microgram.kg-1.min-1. During surgery, the infusions of both ATR and VEC were titrated in increments or decrements of 12.5% to maintain first twitch (T1) suppression of 90-95%. Neuromuscular block was measured by recording the integrated evoked electromyographic response (EMG) of the first dorsal interosseous muscle in response to supramaximal TOF stimuli on the ulnar nerve. The durations of infusion were similar for the two groups (164 +/- 42 and 183 +/- 67 min for ATR and VEC, respectively). The infusion rates of ATR (mean +/- SD) remained between 4.0 +/- 0.7 and 5.0 +/- 1.0 microgram.kg-1.min-1 throughout the study period. In contrast, a progressive decrease (P less than 0.05) in the infusion rate of VEC, from 1.0 to 0.47 +/- 0.13 micrograms.kg-1.min-1, was observed during the study period. The number of adjustments required to maintain 90-95% T1 suppression decreased between the second and fourth hours of administration, but were similar at corresponding times when comparing the two groups.(ABSTRACT TRUNCATED AT 250 WORDS)
进行了一项随机双盲研究,比较在平衡麻醉下长时间手术持续输注阿曲库铵(ATR)和维库溴铵(VEC)时的蓄积倾向和恢复特性。符合条件的受试者年龄在50至75岁之间,无神经肌肉疾病。ATR组(n = 25)患者接受0.25 mg·kg-1的阿曲库铵负荷剂量,随后初始输注速率设定为5.0 μg·kg-1·min-1。VEC组(n = 25)患者接受0.05 mg·kg-1的维库溴铵负荷剂量,随后以1.0 μg·kg-1·min-1的速率输注。手术期间,ATR和VEC的输注量均以12.5%的增量或减量进行滴定,以维持第一个肌颤搐(T1)抑制在90 - 95%。通过记录尺神经上最大强直刺激下第一背侧骨间肌的综合诱发肌电图反应(EMG)来测量神经肌肉阻滞。两组的输注持续时间相似(ATR组和VEC组分别为164±42分钟和183±67分钟)。在整个研究期间,ATR的输注速率(平均值±标准差)保持在4.0±0.7至5.0±1.0 μg·kg-1·min-1之间。相比之下,在研究期间观察到VEC的输注速率从1.0逐渐降低(P < 0.05)至0.47±0.13 μg·kg-1·min-1。维持90 - 95% T1抑制所需的调整次数在给药的第二至第四小时减少,但两组在相应时间相似。(摘要截短至250字)